Essential Sight Saving Treatments in the Midst of COVID Crisis
Patients with sight limiting diseases like Macular Degeneration know the importance of regular treatments to preserve existing vision. The most common treatments to slow vision loss from wet macular degeneration are anti-VEGF intravitreal injections. These drugs are considered the first-line treatment for all stages of wet macular degeneration and are typically scheduled every 4-6 weeks to maintain effectiveness. That all changed in the past month with the outbreak of COVID-19. Both the American Academy of Ophthalmology and CDC have advised limited medical office visits to minimize risk and exposure to the novel coronavirus for patients and staff. To accommodate the situation, Florida Eye Institute quickly prioritized procedures to continue providing care for their most vulnerable patient populations.